AstraZeneca PLC (AZNCF) To Go Ex-Dividend on February 19th

AstraZeneca PLC (OTCMKTS:AZNCFGet Free Report) announced a dividend on Thursday, February 6th,NASDAQ Dividends reports. Shareholders of record on Friday, February 21st will be given a dividend of 2.10 per share on Monday, March 24th. The ex-dividend date is Wednesday, February 19th. This is a boost from AstraZeneca’s previous dividend of $1.00.

AstraZeneca Price Performance

AZNCF opened at $142.85 on Friday. The stock’s 50 day moving average price is $134.39 and its 200-day moving average price is $146.51. AstraZeneca has a 52-week low of $118.16 and a 52-week high of $175.00.

About AstraZeneca

(Get Free Report)

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.

Read More

Receive News & Ratings for AstraZeneca Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca and related companies with MarketBeat.com's FREE daily email newsletter.